These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 8870958)
1. Lack of cardiotoxicity of a new antineoplastic agent, a synthetic derivative of indenoisochinoline: comparison with daunorubicin in rabbits. Gersl V; Mazurová Y; Bajgar J; Mĕlka M; Hrdina R; Palicka V Arch Toxicol; 1996; 70(10):645-51. PubMed ID: 8870958 [TBL] [Abstract][Full Text] [Related]
2. [Effects of new antineoplastic agents (dimethoxybenflurone and Oracin) on the cardiovascular system and other parameters in the rabbit in vivo]. Machácková J; Gersl V; Adamcová M; Mazurová Y; Hrdina R; Mĕlka M; Nobilis M Acta Medica (Hradec Kralove) Suppl; 2000; 43(2):119-38. PubMed ID: 11413675 [TBL] [Abstract][Full Text] [Related]
3. [Plasma levels of troponin T in rabbits after administration of new antineoplastic agents (Oracin and Dimefluron) and daunorubicin]. Adamcová M; Machácková J; Gersl V; Hrdina R; Mazurová Y; Mĕlka M; Nobilis M Acta Medica (Hradec Kralove) Suppl; 2001; 44(1):3-8. PubMed ID: 11892362 [TBL] [Abstract][Full Text] [Related]
4. Cardiac troponin T as a marker of myocardial damage caused by antineoplastic drugs in rabbits. Adamcová M; Gersl V; Hrdina R; Melka M; Mazurová Y; Vávrová J; Palicka V; Kokstein Z J Cancer Res Clin Oncol; 1999; 125(5):268-74. PubMed ID: 10359131 [TBL] [Abstract][Full Text] [Related]
5. Noninvasive polygraphic cardiac changes in daunorubicin-induced cardiomyopathy in rabbits. Gersl V; Hrdina R Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1994; 37(2):49-55. PubMed ID: 7784798 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of cardiac effects of the new antineoplastic drug --dimethoxybenfluron--in the rabbit. Machacková J; Adamcová M; Mazurová Y; Hrdina R; Nobilis M Physiol Res; 2001; 50(5):491-9. PubMed ID: 11702853 [TBL] [Abstract][Full Text] [Related]
7. Study of daunorubicin cardiotoxicity prevention with pyridoxal isonicotinoyl hydrazone in rabbits. Simůnek T; Klimtová I; Kaplanová J; Sterba M; Mazurová Y; Adamcová M; Hrdina R; Gersl V; Ponka P Pharmacol Res; 2005 Mar; 51(3):223-31. PubMed ID: 15661572 [TBL] [Abstract][Full Text] [Related]
8. Stereochemical aspects of carbonyl reduction of the original anticancer drug oracin by mouse liver microsomes and purified 11beta-hydroxysteroid dehydrogenase type 1. Wsól V; Szotáková B; Skálová L; Maser E Chem Biol Interact; 2003 Feb; 143-144():459-68. PubMed ID: 12604232 [TBL] [Abstract][Full Text] [Related]
9. Reduction of chronic daunorubicin cardiotoxicity by ICRF-187 in rabbits. Herman EH; Ferrans VJ; Jordan W; Ardalan B Res Commun Chem Pathol Pharmacol; 1981 Jan; 31(1):85-97. PubMed ID: 6789416 [TBL] [Abstract][Full Text] [Related]
11. Effect of sodium 2,3-dimercaptopropane-1-sulphonate (DMPS) on chronic daunorubicin toxicity in rabbits: comparison with dexrazoxane. Hrdina R; Gersl V; Klimtová I; Simůnek T; Mazurová Y; Machácková J; Adamcová M Acta Medica (Hradec Kralove); 2002; 45(3):99-105. PubMed ID: 12515046 [TBL] [Abstract][Full Text] [Related]
12. Cardiac remodeling and MMPs on the model of chronic daunorubicin-induced cardiomyopathy in rabbits. Adamcová M; Potáčová A; Popelová O; Štěrba M; Mazurová Y; Aupperle H; Geršl V Physiol Res; 2010; 59(5):831-836. PubMed ID: 20406046 [TBL] [Abstract][Full Text] [Related]
13. Protein profiling in daunorubicin-induced cardiomyopathy. Adamcová M; Pelouch V; Gersl V; Kaplanová J; Mazurová Y; Simůnek T; Klimtová I; Hrdina R Gen Physiol Biophys; 2003 Sep; 22(3):411-9. PubMed ID: 14986890 [TBL] [Abstract][Full Text] [Related]
14. Comparative study of chronic toxic effects of daunorubicin and doxorubicin in rabbits. Klimtová I; Simůnek T; Mazurová Y; Hrdina R; Gersl V; Adamcová M Hum Exp Toxicol; 2002 Dec; 21(12):649-57. PubMed ID: 12540035 [TBL] [Abstract][Full Text] [Related]
15. Aldo-keto reductases (AKR) from the AKR1C subfamily catalyze the carbonyl reduction of the novel anticancer drug oracin in man. Wsol V; Szotakova B; Martin HJ; Maser E Toxicology; 2007 Sep; 238(2-3):111-8. PubMed ID: 17618725 [TBL] [Abstract][Full Text] [Related]
16. Changes of some biochemical and hematological parameters following administration of daunorubicin in rabbits. Gersl V; Bajgar J; Krs O; Hrdina R; Vávrová J; Palicka V; Voglová J; Cerman J; Suba P Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1995; 38(2):79-84. PubMed ID: 8584862 [TBL] [Abstract][Full Text] [Related]
17. High-performance liquid chromatography study of stereospecific microsomal enzymes catalysing the reduction of a potential cytostatic drug, oracin. Interspecies comparison. Wsól V; Szotáková B; Kvasnicková E; Fell AF J Chromatogr A; 1998 Feb; 797(1-2):197-201. PubMed ID: 9542111 [TBL] [Abstract][Full Text] [Related]
18. Myocardial toxicity of high-dose cyclophosphamide in rabbits treated with daunorubicin. Isberg B; Paul C; Jönsson L; Svahn U Cancer Chemother Pharmacol; 1991; 28(3):171-80. PubMed ID: 1649704 [TBL] [Abstract][Full Text] [Related]
19. Rabbit model for in vivo study of anthracycline-induced heart failure and for the evaluation of protective agents. Simůnek T; Klimtová I; Kaplanová J; Mazurová Y; Adamcová M; Sterba M; Hrdina R; Gersl V Eur J Heart Fail; 2004 Jun; 6(4):377-87. PubMed ID: 15182761 [TBL] [Abstract][Full Text] [Related]
20. Modulation of caveolins, integrins and plasma membrane repair proteins in anthracycline-induced heart failure in rabbits. Ichikawa Y; Zemljic-Harpf AE; Zhang Z; McKirnan MD; Manso AM; Ross RS; Hammond HK; Patel HH; Roth DM PLoS One; 2017; 12(5):e0177660. PubMed ID: 28498861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]